TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Clarity Pharmaceuticals Ltd. ( (AU:CU6) ) has provided an announcement.
Clarity Pharmaceuticals has announced its upcoming Annual General Meeting (AGM) scheduled for November 25, 2025. The meeting will provide an opportunity for shareholders to hear about the company’s performance over the past year and vote on various resolutions. Shareholders are encouraged to participate either in person or via teleconference, although remote attendees will not be able to vote. The executive team, led by Dr. Alan Taylor, will report on the company’s progress and future plans, with directors recommending a favorable vote on all resolutions.
The most recent analyst rating on (AU:CU6) stock is a Hold with a A$5.00 price target. To see the full list of analyst forecasts on Clarity Pharmaceuticals Ltd. stock, see the AU:CU6 Stock Forecast page.
More about Clarity Pharmaceuticals Ltd.
Clarity Pharmaceuticals is a clinical stage radiopharmaceutical company that focuses on developing innovative treatments for serious diseases. The company specializes in Targeted Copper Theranostics using its SAR Technology Platform, primarily targeting cancer treatments.
Average Trading Volume: 3,601,451
Technical Sentiment Signal: Buy
Current Market Cap: A$1.82B
See more data about CU6 stock on TipRanks’ Stock Analysis page.